Dr Thatcher Heumann, MD, MPH from Vanderbilt-Ingram Cancer Center comments on updates for hepatic, biliary tract, and pancreatic cancers: Locoregional therapy in advanced, liver-dominant HCC, negative results, immunotherapy, and targeted treatment in biliary tract cancer, and readout from the NAPOLI-3 trial in pancreatic cancer.
Ещё видео!